2022-11-25

Un nouveau programme en ligne aide les professionnels de la santé à faire face à la crise des opioïdes

OTTAWA, Nov. 14, 2018 /CNW/ – Healthcare providers have a new online program to help them respond to the growing opioid crisis in Canada.

In virtually every jurisdiction across the country, opioid-related overdoses and deaths have reached crisis levels. Through a new, case-based e-learning program from the Royal College of Physicians and Surgeons of Canada, healthcare providers can learn from experts in pain management about the best ways to deal with these increasingly complex cases.

The online program is one of three new self-assessment programs being offered as part of an innovative pilot collaboration between the Royal College of Physicians and Surgeons of Canada and the MDBriefCase Group. These self-assessment programs are available at no additional charge for Fellows of the Royal College and MOC MAINPORT ePortfolio users. The two other self-assessment programs available are on the topics of CanMEDS and research ethics.

Other healthcare professionals in Canada and abroad will be able to access the programs at a cost of $65 CAD. All programs are available online as of today. Click here to register.

Developed by leading specialists and peer-reviewed by experts in the field, these accredited programs offer unique learning opportunities in English and French, combined with the flexibility and convenience of online delivery.

“Opioid therapy is one of the most controversial and challenging issues facing healthcare professionals today,” said Dr. Andrew Padmos, Royal College CEO.  “Through this course, our Fellows will get the latest information on screening practices, identifying patients at risk of harm, ongoing monitoring, and knowing how to discontinue or taper opioids at the appropriate time.”

The program was developed based on a needs assessment of medical and surgical specialists who identified a number of recurring, complex issues that they face when managing or prescribing opioids for patients with acute or chronic pain.

“It’s a very practical program built around three clinical scenarios that will challenge participants and foster learning through expert feedback,” added Jason Flowerday, CEO of MDBriefCase Group. “This program will be of tangible benefit to any specialist or surgeon prescribing opioids. And, as a member of MDBriefCase, participants will also have free access to our comprehensive library of online accredited courses in more than 20 therapeutic areas.”

About the Royal College of Physicians and Surgeons of Canada 
The Royal College of Physicians and Surgeons of Canada is the home of specialty medicine in Canada, setting the standards for postgraduate medical education, supporting the continuing professional development of 50,000+ Fellows and affiliates, and supporting health system innovations nationwide. To find out more, please visit royalcollege.ca.

About MDBriefCase Group
The MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform. All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 200,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide. mdBriefCasegroup.com

SOURCE MDBriefCase Group Inc.

 rt

For further information: Melissa Nisbett, Senior Communications Specialist, Communications and External Relations, Royal College of Physicians and Surgeons of Canada, mnisbett@royalcollege.ca, T: 613-730-8177 ext. 426, Cell: 613-218-9570

Related Links

https://www.mdbriefcase.com/default.aspx?

Author Agreement

In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:

Review: MDBriefCase is pleased to consider the publication of Your Work on the Website.   The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.   

Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered.  If posted, You will be identified as the author of the Work, or co-author if applicable.  

Grant of Rights:  As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats:  (1) the exclusive right of first publication worldwide;  (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications.  The grant of rights survives termination or expiration of this Agreement.    

Warranty:  You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work.  This warranty survives termination or expiration of this Agreement.

Submission Agreement

Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.

Audience and Appropriate Topics

The  Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished.  When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.

Parameters

Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.

Length of Submissions

Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words. 

Review

MDBriefCase reserves the right to accept or reject any submission  and the right to condition acceptance upon revision of material to conform to its criteria.   

No Compensation

There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal  websites, corporate websites and social media platforms.

Author Agreements

Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement